ACSL4 upregulated by bone morphogenetic protein 4 (BMP4) enhances the cancer cell fatty acid metabolism, which is associated with acquired drug resistance in EGFR-mutant NSCLC cells [9]. The gene discussed is EGFR; the disease is cancer.